medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 1

<< Back Next >>

Med Int Mex 2016; 32 (1)

Predictive value of dynamic of procalcitonin depuration in adults with sepsis

Cedillo-Fernández JM, Palma-Carbajal R, Gómez-Gómez B, Rodríguez- Weber F, Díaz-Greene EJ
Full text How to cite this article

Language: Spanish
References: 10
Page: 89-92
PDF size: 453.59 Kb.


Key words:

procalcitonin, sepsis, septic shock.

ABSTRACT

Procalcitonin quantification has multiple uses, it has been used as a mortality predictor and as a guide for the use of empiric antibiotics; nevertheless, because of variations, various ranges and interindividual variability, its use as a predictor of survival and mortality based in a single procalcitonin absolute value is nowadays considered invalid. Dynamic changes in procalcitonin serum values have shown to be more predictive in severe sepsis and septic shock outcomes than a single procalcitonin value. The results in procalcitonin depuration were compared with different gravity scales such as APACHE II, SOFA and SAPS. Results showed that rapid procalcitonin depuration at 24 and 48 hours is associated with lower mortality rates.


REFERENCES

  1. Bloos F, Reinhart K. Rapid diagnosis of sepsis. Virulence 2014;5:154-160.

  2. Azevedo JR, Torres OJ, Czeczko NG, Tuon FF, et al. Procalcitonin as a prognostic biomarker of severe sepsis and septic shock. Revista do Colegio Brasileiro de Cirurgioes 2012;39:456-461.

  3. Hoeboer SH, Groeneveld AB. Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients. PloS one 2013;8:65564.

  4. Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med 2013;28:285-291.

  5. Hohn A, Schroeder S, Gehrt A, Bernhardt K, et al. Procalcitonin- guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. BMC infectious diseases 2013;13:158.

  6. Song JY, Eun BW, Nahm MH. Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward. Infection & chemotherapy 2013;45:351-366.

  7. Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci 2013;50:23-36.

  8. Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 2011;135:182-189.

  9. Charles PE, Tinel C, Barbar S, Aho S, et al. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Critical Care 2009;13:38.

  10. Patil VK, Morjaria JB, De Villers F, Babu SK. Associations between procalcitonin and markers of bacterial sepsis. Medicina 2012;48:383-387.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2016;32